Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6533
    +0.0033 (+0.51%)
     
  • OIL

    82.95
    +0.14 (+0.17%)
     
  • GOLD

    2,342.20
    +3.80 (+0.16%)
     
  • Bitcoin AUD

    97,673.64
    -3,972.04 (-3.91%)
     
  • CMC Crypto 200

    1,353.07
    -29.50 (-2.14%)
     
  • AUD/EUR

    0.6088
    +0.0017 (+0.28%)
     
  • AUD/NZD

    1.0953
    +0.0012 (+0.11%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,089.74
    +49.36 (+0.61%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    17,949.57
    -139.13 (-0.77%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Why 23andMe Stock Has Jumped 16% So Far This Week

Why 23andMe Stock Has Jumped 16% So Far This Week

What happened Shares of the genetic-testing company 23andMe (NASDAQ: ME) gained another 16% through Thursday's close this week, according to data from S&P Global Market Intelligence. The biotech's stock is now up by more than 34% over the past two weeks.